X-Vax Technology Company

X-VAX is a biotech company committed to developing vaccines against pathogens acquired by mucosal infection such as herpes.


Investors

Last Funding Type: Series A
Headquarters: Jupiter, Florida, United States
Founded Date: 2015
Investor Type: Early Stage Venture
Last Funding Date: 2019
Total Funding: 56000000
Employee Number: 11-50
Estimated Revenue: Less than $1M
Investors Number: 7
Industry: Biotechnology, Health Care, Medical